You are here: Home: PCU 2 | 2006: Case 2: Select publications

SELECT PUBLICATIONS

Bolla M et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997;337(5):295-300. Abstract

Crawford ED. Early versus late hormonal therapy: Debating the issues. Urology 2003;61(2 Suppl 1):8-13. Abstract

Loblaw DA et al. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol 2004;22(14):2927-41. Abstract

Messing E. The timing of hormone therapy for men with asymptomatic advanced prostate cancer. Urol Oncol 2003;21(4):245-54. Abstract

Messing EM et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 1999;341(24):1781-8. Abstract

Walsh PC et al. A structured debate: Immediate versus deferred androgen suppression in prostate cancer — Evidence for deferred treatment. J Urol 2001;166(2):508-15. Abstract

Wirth MP et al; Casodex Early Prostate Cancer Trialists’ Group. Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: Results from the second analysis of the early prostate cancer program at median follow- up of 5.4 years. J Urol 2004;172(5 Pt 1):1865-70. Abstract

 

 

 

 

 

 

 

 

Home